CN104140952B - 透明质酸酶及其制备方法 - Google Patents
透明质酸酶及其制备方法 Download PDFInfo
- Publication number
- CN104140952B CN104140952B CN201410388804.3A CN201410388804A CN104140952B CN 104140952 B CN104140952 B CN 104140952B CN 201410388804 A CN201410388804 A CN 201410388804A CN 104140952 B CN104140952 B CN 104140952B
- Authority
- CN
- China
- Prior art keywords
- hyaluronidase
- acid
- sodium
- preparation
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000001974 Hyaluronidases Human genes 0.000 title claims abstract description 44
- 108010003272 Hyaluronate lyase Proteins 0.000 title claims abstract description 43
- 229960002773 hyaluronidase Drugs 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 6
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 6
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 6
- 239000012498 ultrapure water Substances 0.000 claims description 6
- 102000009027 Albumins Human genes 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 4
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 4
- 229930182566 Gentamicin Natural products 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 229960002518 gentamicin Drugs 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 229960002648 alanylglutamine Drugs 0.000 claims description 2
- 108010044940 alanylglutamine Proteins 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000001540 sodium lactate Substances 0.000 claims description 2
- 229940005581 sodium lactate Drugs 0.000 claims description 2
- 235000011088 sodium lactate Nutrition 0.000 claims description 2
- 229940054269 sodium pyruvate Drugs 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims 1
- 235000019341 magnesium sulphate Nutrition 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 15
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 239000003899 bactericide agent Substances 0.000 abstract description 7
- 102000002322 Egg Proteins Human genes 0.000 abstract description 6
- 108010000912 Egg Proteins Proteins 0.000 abstract description 6
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- 210000004681 ovum Anatomy 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 5
- 238000000338 in vitro Methods 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 210000001161 mammalian embryo Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000003204 osmotic effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 239000002158 endotoxin Substances 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 238000013190 sterility testing Methods 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000002459 blastocyst Anatomy 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002510 pyrogen Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
项目 | 配方1 | 配方2 | 配方3 |
pH值 | 7.33 | 7.35 | 7.35 |
渗透压mOsm/Kg | 275 | 273 | 280 |
细胞毒性 | 合格 | 合格 | 合格 |
皮内刺激 | 无皮内刺激 | 无皮内刺激 | 无皮内刺激 |
致敏 | 无致敏反应 | 无致敏反应 | 无致敏反应 |
热原 | 无热原 | 无热原 | 无热原 |
无菌检测 | 无菌 | 无菌 | 无菌 |
细菌内毒素检测 | 合格 | 合格 | 合格 |
体外鼠胚试验 | 囊胚合格率81% | 囊胚合格率85% | 囊胚合格率82% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410388804.3A CN104140952B (zh) | 2014-08-08 | 2014-08-08 | 透明质酸酶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410388804.3A CN104140952B (zh) | 2014-08-08 | 2014-08-08 | 透明质酸酶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104140952A CN104140952A (zh) | 2014-11-12 |
CN104140952B true CN104140952B (zh) | 2018-03-16 |
Family
ID=51850294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410388804.3A Expired - Fee Related CN104140952B (zh) | 2014-08-08 | 2014-08-08 | 透明质酸酶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104140952B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106916800A (zh) * | 2017-02-15 | 2017-07-04 | 瑞柏生物(中国)股份有限公司 | 一种重组人颗粒细胞酶溶液及其制备方法 |
CN110643569B (zh) * | 2019-11-29 | 2020-05-26 | 广州达瑞生殖技术有限公司 | 一种颗粒细胞剥离液及其制备方法 |
CN111471639A (zh) * | 2020-05-29 | 2020-07-31 | 东蕴医疗科技(上海)有限公司 | 一种用于人类辅助生殖的颗粒细胞去除液及其制备方法 |
CN111778202B (zh) * | 2020-07-10 | 2022-10-28 | 深圳韦拓生物科技有限公司 | 一种颗粒细胞去除液及其制备方法 |
CN115287275B (zh) * | 2022-09-13 | 2024-03-15 | 水羊化妆品制造有限公司 | 一种纯化透明质酸酶的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101679944A (zh) * | 2007-05-01 | 2010-03-24 | 维特罗莱夫瑞典有限公司 | 用于发育细胞的含有高浓度硫辛酸的培养基 |
CN102154198A (zh) * | 2010-12-16 | 2011-08-17 | 西北农林科技大学 | 一种简易的卵母细胞体外成熟培养方法 |
CN103275930A (zh) * | 2013-06-20 | 2013-09-04 | 江苏皓康生物医药科技有限公司 | 一种卵母细胞体外成熟培养液及其制备方法 |
CN103525759A (zh) * | 2013-10-06 | 2014-01-22 | 吉林大学 | 蛹虫草素在猪小卵泡卵母细胞体外成熟培养中的应用 |
-
2014
- 2014-08-08 CN CN201410388804.3A patent/CN104140952B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101679944A (zh) * | 2007-05-01 | 2010-03-24 | 维特罗莱夫瑞典有限公司 | 用于发育细胞的含有高浓度硫辛酸的培养基 |
CN102154198A (zh) * | 2010-12-16 | 2011-08-17 | 西北农林科技大学 | 一种简易的卵母细胞体外成熟培养方法 |
CN103275930A (zh) * | 2013-06-20 | 2013-09-04 | 江苏皓康生物医药科技有限公司 | 一种卵母细胞体外成熟培养液及其制备方法 |
CN103525759A (zh) * | 2013-10-06 | 2014-01-22 | 吉林大学 | 蛹虫草素在猪小卵泡卵母细胞体外成熟培养中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104140952A (zh) | 2014-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104140949B (zh) | 囊胚培养液及其制备方法 | |
CN104140952B (zh) | 透明质酸酶及其制备方法 | |
CN104140950A (zh) | 卵裂培养液及其制备方法 | |
CN104140948A (zh) | 卵子与胚胎处理液及其制备方法 | |
CN104164401A (zh) | 精子洗涤液及其制备方法 | |
CN109628380A (zh) | 一种人体外受精液及其制备方法 | |
CN108251353A (zh) | 一种人胚胎体外培养液及培养系统 | |
CN106237339B (zh) | 一种冻干疫苗耐热保护剂及其制备方法和应用 | |
CN108587970B (zh) | 一种产酸克雷伯氏菌及其在促进潞党参生长中的应用 | |
CN104164400A (zh) | 体外受精液及其制备方法 | |
CN104130974A (zh) | 精子制动液及其制备方法 | |
CN109337862A (zh) | 一种精子洗涤液及其制备方法和应用 | |
CN104017728A (zh) | 用于人类卵子与精子体外授精及胚胎早期发育的培养装置、培养液及培养体系 | |
CN103710290A (zh) | 源于广西巴马长寿村的益生菌鼠李糖乳杆菌hsryfm1301及其应用 | |
CN106434843A (zh) | 一种选择性分离培养b群链球菌的培养基及其制备方法 | |
WO2004063392A2 (es) | Medio de cultivo selectivo para el aislamiento y deteccion de especies del genero streptococcus | |
CN112574924B (zh) | 一种枯草芽孢杆菌菌株及其微生态制剂和应用 | |
CN110205355A (zh) | 一种微生物高灵敏检测培养基及其制备方法和应用 | |
CN108949589A (zh) | 一种液体微生物菌肥中有效菌的检测方法 | |
CN101921719B (zh) | 军团菌运送增菌培养基 | |
CN102146429A (zh) | 溶藻弧菌选择性鉴别培养基 | |
CN110669724A (zh) | 一种囊胚培养液及其制备方法 | |
US8313938B1 (en) | Culture medium for cultivation of microorganisms | |
CN110452868A (zh) | 一种一步式胚胎培养液 | |
CN103865849B (zh) | 用于克罗诺菌冷热损伤修复的前增菌液体培养基 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Weihua Inventor after: Lv Xinrong Inventor after: Liu Meijing Inventor after: Lv Ruju Inventor after: Wang Xiaolin Inventor after: Lu Bin Inventor after: Ma Yiwen Inventor after: Tian Yan Inventor before: Wang Weihua Inventor before: Lv Ruju Inventor before: Liu Meijing Inventor before: Zhuang Wei Inventor before: Wang Yingchao |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180316 Termination date: 20180808 |